Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. Federal Trade Commission
MedTech
Alcon, Lensar drop $356M deal after black eye from FTC
The FTC threatened to challenge the deal that would have seen Alcon acquire Lensar’s robotic laser systems for cataract surgery.
Conor Hale
Mar 17, 2026 11:00am
FTC wins case blocking Edwards' $945M JenaValve takeover
Jan 12, 2026 8:15am
Pfizer finalizes Metsera buy after contentious Novo bidding war
Nov 13, 2025 12:43pm
FTC tells Novo that Metsera offer may violate US merger law
Nov 5, 2025 4:26pm
FTC sues to block Surmodics acquisition over coating competition
Mar 7, 2025 11:00am
AbbVie CEO Gonzalez brushes off FTC concerns for Cerevel buy
Dec 7, 2023 11:26am
